The New York Times reported: “Following the guidance of the Centers for Disease Control and Prevention, every patient entering one of the city’s hospitals who has fever, headache and other symptoms associated with Ebola (as well as countless other ailments), is asked two new questions.”
“Have you traveled to or from West African countries in the last 10 days? Have you been in contact with an Ebola patient or with anyone who has been in contact with an Ebola patient?”
Forbes reported: “Given the scope of the Ebola outbreak unfolding in Western Africa, it seems possible that a case will eventually emerge in the U.S. We could even see an isolated cluster of infections in an American city.”
“Considering the nature of the Ebola virus, and the medical infrastructure we have to combat its spread, the diagnosis of some cases on American soil shouldn’t be reason to panic. We have a plethora of tools and public health practices to readily combat its spread. Yet because the virus is so dangerous, and feared, its arrival in America would likely to trigger a robust response from our public health establishment.”
The New York Times reported: “The doctor who had been leading Sierra Leone’s battle against the Ebola outbreak was now fighting for his own life, and his international colleagues faced a fateful decision: whether to give him a drug that had never before been tested on people.
Would the drug, known as ZMapp, help the stricken doctor? Or would it perhaps harm or even kill one of the country’s most prominent physicians, a man considered a national hero, shattering the already fragile public trust in international efforts to contain the world’s worst Ebola outbreak?
Modern Healthcare reported: “The company that developed an experimental drug used against the Ebola virus said it has exhausted its supply after shipping doses to Africa to treat two Liberian doctors.
On July 29, 2014, Thomson Reuters awarded an Impact Factor of 5.486 to the open access journal Molecular Autism. This represents the highest Impact Factor for any journal dedicated to autism or related neurodevelopmental conditions.
The journal was created in 2010, by Professor Joseph Buxbaum, Director of the Seaver Autism Center and Professor of Psychiatry, Neuroscience, and Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, and Professor Simon Baron-Cohen, Director of the Autism Research Centre at the University of Cambridge. The goal of the journal was to provide an outlet for the volume of exciting genetic and other molecular autism research papers, and to make this cutting-edge autism research available freely via open access. In the past four years, Molecular Autism has grown and now publishes approximately five articles per month.
The New York Times reported: “The Ebola outbreak in West Africa is so out of control that governments there have revived a disease-fighting tactic not used in nearly a century: the “cordon sanitaire,” in which a line is drawn around the infected area and no one is allowed out.
Cordons, common in the medieval era of the Black Death, have not been seen since the border between Poland and Russia was closed in 1918 to stop typhus from spreading west. They have the potential to become brutal and inhumane. Centuries ago, in their most extreme form, everyone within the boundaries was left to die or survive, until the outbreak ended.
New Jersey Spotlight reported: “Worldwide alarm over the West African Ebola virus outbreak has highlighted the fact that such infectious diseases are spreading due to increased travel.
And that globalization of viruses has led New Jersey health officials to take precautions against tropical diseases, including testing for a pair of mosquito-borne viruses.
They’re also alerting healthcare providers to the symptoms of Ebola, which led to one state resident being isolated for part of last week until it was determined that the person wasn’t exposed to Ebola.
The New York Times reported: “Erica J. Sison has dealt with sick and dead dogs and cats, 40 dead lab rats in bags, trophy animals, cooked monkey meat on sticks, human skulls from Indonesia and a live Asian bat that flew out of an airplane cargo hold.
Now she is poised for Ebola, and has seen three false alarms in the last two weeks.
Ms. Sison, the quarantine officer in charge at Newark Liberty International Airport, is on the front lines of a complex system developed to protect United States borders from a “Contagion”-like invasion of rare foreign diseases. It is, she says, a bit anxiety provoking.
“We use a scoring system that predicts the likelihood of survival,” said Dr. Hassan Khouli, chief of the critical care section and chair of the ethics committee at Mount Sinai Roosevelt in New York City. Khouli serves on the state’s task force that is updating the guideline to include children. “The ethical principle driving this is to save the most lives.”
“If there is a test but there’s problems with it, I often go over this with a patient and how to decide if it’s necessary.”
Add mammography to the list of cancer screenings where evidence has challenged “best practices.”
Recently Dr. Sanjay Gupta of CNN reported in EveryDay Health that while early cancer detection can save lives, recent studies raise new doubts about the benefits of screening without considering the risks as well.